vs
Esperion Therapeutics, Inc.（ESPR）与1 800 FLOWERS COM INC（FLWS）财务数据对比。点击上方公司名可切换其他公司
1 800 FLOWERS COM INC的季度营收约是Esperion Therapeutics, Inc.的1.7倍（$293.0M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -11.6%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs -12.1%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
1 800 FLOWERS COM INC是美国知名的全渠道鲜花礼品零售企业，主营鲜花花束、礼品篮、美食礼盒、定制礼物及家居装饰品，服务北美地区个人及企业客户，覆盖节日、生日、纪念日等各类送礼场景。
ESPR vs FLWS — 直观对比
营收规模更大
FLWS
是对方的1.7倍
$168.4M
营收增速更快
ESPR
高出155.3%
-11.6%
两年增速更快
ESPR
近两年复合增速
-12.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $293.0M |
| 净利润 | — | $-100.1M |
| 毛利率 | — | 33.2% |
| 营业利润率 | 50.6% | 34.5% |
| 净利率 | — | -34.1% |
| 营收同比 | 143.7% | -11.6% |
| 净利润同比 | — | 44.3% |
| 每股收益（稀释后） | $0.32 | $-1.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRFLWS
| Q1 26 | — | $293.0M | ||
| Q4 25 | $168.4M | $702.2M | ||
| Q3 25 | $87.3M | $215.2M | ||
| Q2 25 | $82.4M | $336.6M | ||
| Q1 25 | $65.0M | $331.5M | ||
| Q4 24 | $69.1M | $775.5M | ||
| Q3 24 | $51.6M | $242.1M | ||
| Q2 24 | $73.8M | — |
净利润ESPRFLWS
| Q1 26 | — | $-100.1M | ||
| Q4 25 | — | $70.6M | ||
| Q3 25 | $-31.3M | $-53.0M | ||
| Q2 25 | $-12.7M | $-51.9M | ||
| Q1 25 | $-40.5M | $-178.2M | ||
| Q4 24 | — | $64.3M | ||
| Q3 24 | $-29.5M | $-34.2M | ||
| Q2 24 | $-61.9M | — |
毛利率ESPRFLWS
| Q1 26 | — | 33.2% | ||
| Q4 25 | — | 42.1% | ||
| Q3 25 | — | 35.7% | ||
| Q2 25 | — | 35.5% | ||
| Q1 25 | — | 31.7% | ||
| Q4 24 | — | 43.3% | ||
| Q3 24 | — | 38.1% | ||
| Q2 24 | — | — |
营业利润率ESPRFLWS
| Q1 26 | — | 34.5% | ||
| Q4 25 | 50.6% | 10.6% | ||
| Q3 25 | -11.4% | -23.5% | ||
| Q2 25 | 8.6% | -16.5% | ||
| Q1 25 | -34.0% | -58.4% | ||
| Q4 24 | -6.4% | 11.7% | ||
| Q3 24 | -31.0% | -19.4% | ||
| Q2 24 | 3.5% | — |
净利率ESPRFLWS
| Q1 26 | — | -34.1% | ||
| Q4 25 | — | 10.0% | ||
| Q3 25 | -35.9% | -24.6% | ||
| Q2 25 | -15.4% | -15.4% | ||
| Q1 25 | -62.2% | -53.8% | ||
| Q4 24 | — | 8.3% | ||
| Q3 24 | -57.2% | -14.1% | ||
| Q2 24 | -83.9% | — |
每股收益（稀释后）ESPRFLWS
| Q1 26 | — | $-1.56 | ||
| Q4 25 | $0.32 | $1.10 | ||
| Q3 25 | $-0.16 | $-0.83 | ||
| Q2 25 | $-0.06 | $-0.80 | ||
| Q1 25 | $-0.21 | $-2.80 | ||
| Q4 24 | $-0.14 | $1.00 | ||
| Q3 24 | $-0.15 | $-0.53 | ||
| Q2 24 | $-0.33 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $50.7M |
| 总债务越低越好 | — | $24.0M |
| 股东权益账面价值 | $-302.0M | $192.5M |
| 总资产 | $465.9M | $679.9M |
| 负债/权益比越低杠杆越低 | — | 0.12× |
8季度趋势，按日历期对齐
现金及短期投资ESPRFLWS
| Q1 26 | — | $50.7M | ||
| Q4 25 | $167.9M | $193.3M | ||
| Q3 25 | $92.4M | $7.7M | ||
| Q2 25 | $86.1M | $46.5M | ||
| Q1 25 | $114.6M | $84.7M | ||
| Q4 24 | $144.8M | $247.2M | ||
| Q3 24 | $144.7M | $8.4M | ||
| Q2 24 | $189.3M | — |
总债务ESPRFLWS
| Q1 26 | — | $24.0M | ||
| Q4 25 | — | $123.5M | ||
| Q3 25 | — | $128.9M | ||
| Q2 25 | — | $134.8M | ||
| Q1 25 | — | $142.3M | ||
| Q4 24 | — | $157.5M | ||
| Q3 24 | — | $172.3M | ||
| Q2 24 | — | — |
股东权益ESPRFLWS
| Q1 26 | — | $192.5M | ||
| Q4 25 | $-302.0M | $289.7M | ||
| Q3 25 | $-451.4M | $217.5M | ||
| Q2 25 | $-433.5M | $268.3M | ||
| Q1 25 | $-426.2M | $317.7M | ||
| Q4 24 | $-388.7M | $495.1M | ||
| Q3 24 | $-370.2M | $433.4M | ||
| Q2 24 | $-344.2M | — |
总资产ESPRFLWS
| Q1 26 | — | $679.9M | ||
| Q4 25 | $465.9M | $893.1M | ||
| Q3 25 | $364.0M | $840.5M | ||
| Q2 25 | $347.1M | $772.6M | ||
| Q1 25 | $324.0M | $806.2M | ||
| Q4 24 | $343.8M | $1.1B | ||
| Q3 24 | $314.1M | $1.0B | ||
| Q2 24 | $352.3M | — |
负债/权益比ESPRFLWS
| Q1 26 | — | 0.12× | ||
| Q4 25 | — | 0.43× | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.45× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $42.9M |
| 自由现金流经营现金流 - 资本支出 | — | $20.0M |
| 自由现金流率自由现金流/营收 | — | 6.8% |
| 资本支出强度资本支出/营收 | 0.0% | 7.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $140.5M |
8季度趋势，按日历期对齐
经营现金流ESPRFLWS
| Q1 26 | — | $42.9M | ||
| Q4 25 | $45.2M | $309.9M | ||
| Q3 25 | $-4.3M | $-139.0M | ||
| Q2 25 | $-31.4M | $-27.1M | ||
| Q1 25 | $-22.6M | $-150.6M | ||
| Q4 24 | $-35.0M | $328.5M | ||
| Q3 24 | $-35.3M | $-177.2M | ||
| Q2 24 | $-7.2M | — |
自由现金流ESPRFLWS
| Q1 26 | — | $20.0M | ||
| Q4 25 | — | $302.2M | ||
| Q3 25 | — | $-145.6M | ||
| Q2 25 | — | $-36.1M | ||
| Q1 25 | — | $-160.0M | ||
| Q4 24 | — | $317.6M | ||
| Q3 24 | $-35.5M | $-189.3M | ||
| Q2 24 | $-7.3M | — |
自由现金流率ESPRFLWS
| Q1 26 | — | 6.8% | ||
| Q4 25 | — | 43.0% | ||
| Q3 25 | — | -67.7% | ||
| Q2 25 | — | -10.7% | ||
| Q1 25 | — | -48.3% | ||
| Q4 24 | — | 41.0% | ||
| Q3 24 | -68.7% | -78.2% | ||
| Q2 24 | -9.9% | — |
资本支出强度ESPRFLWS
| Q1 26 | — | 7.8% | ||
| Q4 25 | 0.0% | 1.1% | ||
| Q3 25 | 0.0% | 3.1% | ||
| Q2 25 | 0.0% | 2.7% | ||
| Q1 25 | 0.0% | 2.8% | ||
| Q4 24 | 0.0% | 1.4% | ||
| Q3 24 | 0.3% | 5.0% | ||
| Q2 24 | 0.1% | — |
现金转化率ESPRFLWS
| Q1 26 | — | — | ||
| Q4 25 | — | 4.39× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 5.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
FLWS
| Consumer Floral & Gifts | $159.4M | 54% |
| Gourmet Foods & Gift Baskets | $106.9M | 36% |
| BloomNet | $26.9M | 9% |
| Corporate | $50.0K | 0% |
